Abstract
Granulomatosis with polyangitis (GPA, Wegener's granulomatosis) is characterized by a granulomatous inflammation of the respiratory tract and a necrotizing ANCA-associated small to medium-size vessel vasculitis with a predilection for the lungs (pulmonary capillaritis) and kidneys (necrotizing glomerulonephritis). The disease evolves stage-wise and typically starts as inflammation of the respiratory tract followed by development of systemic vasculitis manifestations. Today, treatment is evidence-based and adapted according to activity and disease stage which has resulted in a significant improvement in long-term outcome. Early mortality during the first year of treatment poses one of the main problems and is a result of infections under immunosuppressive treatment. Furthermore, treatment of refractory disease activity which is often represented by granulomatous manifestations is still a challenge and may result in significant organ damage if not treated successfully.
Translated title of the contribution | Update on granulomatosis with polyangitis (GPA, Wegener's granulomatosis) |
---|---|
Original language | German |
Journal | Zeitschrift fur Rheumatologie |
Volume | 71 |
Issue number | 9 |
Pages (from-to) | 745-753 |
Number of pages | 9 |
ISSN | 0340-1855 |
DOIs | |
Publication status | Published - 11.2012 |
Research Areas and Centers
- Academic Focus: Center for Infection and Inflammation Research (ZIEL)